Clopidogrel (plavix)

J Comin, D Kallmes - American journal of neuroradiology, 2011 - Am Soc Neuroradiology
Clopidogrel is an inhibitor of platelet aggregation, indicated for the prevention of ischemic
stroke and in-stent thrombosis. However, it has a number of drawbacks, including an …

The role of platelets in ischemic stroke

GJ Del Zoppo - Neurology, 1998 - AAN Enterprises
Platelets have assumed a role in the development of focal cerebral ischemia by virtue of
their participation in thromboemboli that may initiate stroke symptoms. Platelets are one …

Clopidogrel and its use in stroke patients

PB Gorelick, DF Hanley Jr - Stroke, 1998 - Am Heart Assoc
Substantial clinical data support the use of antiplatelet therapy in reducing the incidence of
secondary atherothrombotic events in individuals who have experienced a transient …

Clopidogrel for cerebrovascular prevention

M Paciaroni, J Bogousslavsky - Cerebrovascular Diseases, 1999 - karger.com
Ischemic stroke, myocardial infarction and peripheral arterial disease are different clinical
manifestations commonly due to the same underlying disease, ie atherosclerosis with …

Drug evaluation of clopidogrel in patients with ischemic stroke

AE Hassan, H Zacharatos, M Fareed… - Expert opinion on …, 2007 - Taylor & Francis
Clopidogrel is an effective antiplatelet medication used for the secondary prevention of
ischemic events in patients with various cardiovascular, cerebrovascular and peripheral …

Evolving perspectives on clopidogrel in the treatment of ischemic stroke

P Gorelick, O Sechenova… - Journal of …, 2006 - journals.sagepub.com
Antiplatelet therapy is indicated for the treatment of ischemic stroke or transient ischemic
attack (TIA). Aspirin reduces subsequent occlusive vascular events, including recurrent …

Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist

M Fisher - Archives of neurology, 2006 - jamanetwork.com
The secondary prevention of ischemic stroke is aided by the use of antiplatelet therapy, and
the predominant current choices are aspirin, aspirin plus extended-release dipyridamole …

[HTML][HTML] Prevalence and clinical characteristics of intracerebral hemorrhages associated with clopidogrel

SM Cordina, AE Hassan… - Journal of Vascular and …, 2009 - ncbi.nlm.nih.gov
Background: As clopidogrel is being increasingly used, intracerebral hemorrhage (ICH)
associated with clopidogrel are expected to increase. We assessed the prevalence and …

Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience

MFK Suri, HM Hussein, MM Abdelmoula… - Medical Science …, 2008 - medscimonit.com
Medical Science Monitor | Safety and tolerability of 600 mg clopidogrel bolus in patients with
acute ischemic stroke: preliminary experience - Article abstract #869394 Logo Medical Science …

Clopidogrel two doses comparative 1-year assessment of safety and efficacy (COMPASS) study in Japanese patients with ischemic stroke

S Uchiyama, N Tanahashi, K Minematsu… - Cerebrovascular …, 2012 - karger.com
Background: Clopidogrel 75 mg once daily is licensed in Japan for the prevention of
recurrent ischemic cerebrovascular events in adults as the usual dosage. However, a lower …